Professor Roger Daly, Head of the Signalling Network Laboratory, Monash Biomedicine Discovery Institute

“They [BioCurate] change your way of thinking as an academic researcher. They [BioCurate] highlight things which are really critical to potential commercialisation of a project, which you may not have thought of.”

Dr Linda Pullan, Director, Pullan Consulting, CA, USA and member of ISAG

“BioCurate brings deep industry perspective to select opportunities most likely to appeal to biotechnology and pharmaceutical companies, to confirm or extend the properties essential to entice those partners, and to communicate the science in a way that enables ready assessment of fit. This is hugely valuable to industry licensing efforts and will increase the probability of commercialization of the academic work.

I expect BioCurate to be on the top of the list of places where industry will hunt for early drug candidates.”

Professor Christoph Hagemeyer, Monash University

“We are very excited to bring our novel antibody from the bench closer to the bedside with help from the great team at BioCurate and make an impact in the cardiovascular disease indication. Our antibody targets a never before explored thrombotic mechanism that can potentially provide anti-thrombotic therapy without adverse effects.”

Penelope Lane, Senior Business Development Manager, the University of Melbourne

“Working with the team at BioCurate towards translation and commercialisation of medical research from the University of Melbourne has been a comprehensive, professional and considered experience, allowing the researchers, commercialisation teams and funds to successfully navigate investment into early stage medical research.

Collaboration of this nature is a best practice example in support of a truly innovative ecosystem for medical research.”